{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack
- RxCUI
- 1373503
- RxNorm name
- {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack
- Display name
- {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack
- Full name
- {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack
- Term type
- GPCK
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rosyrah | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | Xiromed, LLC | d2f0af55-205f-df9c-c572-1f7b14976655 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 1373503 |
| Rivelsa | LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | 822e56c6-562f-4299-bf4f-eaee0c0f2b7a | 2024-10-22 | Boxed warning, Warnings, Adverse reactions | 1373503 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | 5c1d0a3a-1b24-44a0-9c53-224365b65945 | 2023-05-31 | Boxed warning, Warnings, Adverse reactions | 1373503 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 822e56c6-562f-4299-bf4f-eaee0c0f2b7a | {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [GPCK] · Eth estra 0.01 MG (7) Oral Tablet / Eth estra-Levonorgest 0.02-0.15 MG (42) Oral Tablet / Eth estra-Levonorgest 0.025-0.15 MG (21) Oral Tablet / Eth estra-Levonorgest 0.03-0.15 MG (21) Oral Tablet 3 Month Pack [PSN] | 2 | 13 | These highlights do not include all the information needed to use RIVELSA safely and effectively. See full prescribing information for RIVELSA. RIVELSA ® (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1982 | 20241022 |
| 5c1d0a3a-1b24-44a0-9c53-224365b65945 | {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [GPCK] · Eth estra 0.01 MG (7) Oral Tablet / Eth estra-Levonorgest 0.02-0.15 MG (42) Oral Tablet / Eth estra-Levonorgest 0.025-0.15 MG (21) Oral Tablet / Eth estra-Levonorgest 0.03-0.15 MG (21) Oral Tablet 3 Month Pack [PSN] | 2 | 7 | These highlights do not include all the information needed to use LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS, safely and effectively. See full prescribing information for LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS. LEVONORGESTREL and ETHINYL ESTRADIOL tablets, and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 1982 | 20230531 |
| d2f0af55-205f-df9c-c572-1f7b14976655 | {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [GPCK] · Eth estra 0.01 MG (7) Oral Tablet / Eth estra-Levonorgest 0.02-0.15 MG (42) Oral Tablet / Eth estra-Levonorgest 0.025-0.15 MG (21) Oral Tablet / Eth estra-Levonorgest 0.03-0.15 MG (21) Oral Tablet 3 Month Pack [PSN] | 2 | 2 | These highlights do not include all the information needed to use ROSYRAH, safely and effectively. See full prescribing information for ROSYRAH. ROSYRAH, for oral use Initial U.S. Approval: 1982 | 20251110 |